期刊文献+

靶向Pokemon基因shRNA重组质粒的构建及其在CNE2细胞的筛选 被引量:1

Construction of short hairpin RNA recombinant plasmids targeting human Pokemon gene and screening in CNE2 cells
下载PDF
导出
摘要 目的:构建3个靶向Pokemon基因的短发夹RNA(shRNA)真核表达载体,在鼻咽癌细胞株CNE2中筛选出干扰效果最佳的载体。方法:依据shRNA设计原则,针对Pokemon mRNA序列设计并化学合成3对RNA干扰序列,经酶切、连接和转化,插入pRNAT-U6.1/Neo质粒,经DNA测序验证。脂质体介导shRNA重组质粒及空白质粒转染CNE2细胞,荧光定量PCR和Western blot检测Pokemon在mRNA和蛋白水平的表达,转染空白质粒的CNE2作为阴性对照,未加处理的CNE2作为空白对照。结果:DNA测序结果显示shRNA片段与设计序列一致;转染各重组质粒后的CNE2细胞,与阴性对照相比,Pokemon基因在mRNA和蛋白水平均有下调表达,其中以shRNA2重组质粒干扰Pokemon表达的作用最显著。结论:筛选出高效干扰Pokemon表达的重组质粒shRNA2,为研究Pokemon基因在鼻咽癌发生发展中的作用提供有效的研究工具。 Objective:To construct three short hairPin RNA( shRNA)recombinant Plasmids targeting human Pokemon gene and screen a Plasmid which can block the Pokemon exPression at maximal degree in nasoPharyngeal carcinoma( NPC)CNE2 cells. Methods:Three shRNAs were designed according to the coding sequences of the Pokemon gene. The shRNA sequences were inserted into PRNAT - U6. 1 / Neo during restriction enzyme,connection, transformation and DNA sequencing. The recombinant Plasmids and blank Plasmid were transfected into CNE2 cells using LiPofectamine 2000. The exPression of Pokemon mRNA and Protein was detected by real time Polymerase chain reaction(PCR)and Western blot,the transfected blank Plasmid CNE2 was used as a negative control,the untreated CNE2 was used as a blank control. Results:The results of DNA sequencing showed shRNA fragments were accordance with the designed sequences. ComParing with the negative control,the Pokemon mRNA and Protein exPression levels of the shRNA grouPs were down - regulated. The Pokemon results of shRNA2 grouP was lowest. Conclusion:Construc-tion and screening shRNA recombinant Plasmids targeting human Pokemon gene can Provide an effective tool for fur-ther studying the role of Pokemon gene in occurrence and develoPment of NPC.
出处 《现代肿瘤医学》 CAS 2014年第5期994-997,共4页 Journal of Modern Oncology
基金 广西壮族自治区自然科学基金面上项目(编号:2011 GXNSFA018308) 广西壮族自治区卫生厅自筹课题(编号:Z2013389)
关键词 POKEMON SHRNA 构建 筛选 CNE2 Pokemon shRNA construction screening CNE2
  • 相关文献

参考文献15

  • 1Bardwell VJ,Treisman R. The POZ domain:a conserved protein - protein interaction motif[J]. Genes Dev, 1994, 8 (14) : 1664 - 1677.
  • 2Kelly KF, Daniel JM. POZ for effect - POZ - ZF transcription fac- tors in cancer and development [J]. Trends Cell Biol, 2006, 16 (11) :578 -587.
  • 3Maeda T, Hobbs RM, Merhoub T, et al. Role of the proto -onco- gene pokemon cellular transformation and ARF repression [ J J. Na- ture,2005,433 (7023) :278 -285.
  • 4Wei KR, Yu YL, Yang YY, et al. Epidemiological trends of naso- pharyngeal carcinoma in China [ J ]. Asian Pac J Cancer Prey, 2010,11(1) :29 -32.
  • 5Huang TR, Zhang SW, Chen WQ, et al. Trends in nasopharyngeal carcinoma mortality in China, 1973 - 2005 [ J ]. Asian Pac J Cancer Prey,2012,13(6) :2495 -2502.
  • 6Jiao W, Liu F, Tang FZ, et al. Expression of proto - oncogene Poke- mon in nasopharyngeal carcinoma cell lines and tissues[ J]. Asian Pac J Cancer Prey,2013,14( 11 ) :56.
  • 7Izquierdo M. Short interfering RNAs as a tool for cancer gene thera- py [ J ]. Cancer Gene Therapy,2005,12 ( 3 ) : 217 - 227.
  • 8Reynolds A, Leake D, Boese Q, et al. Rational siRNA design for RNA interference [ J ]. Nat Biotechno1,2004,22 ( 3 ) : 326 - 330.
  • 9Hannon GJ. RNA interference [ J ]. Nature,2002,418 (6893) : 38 - 39.
  • 10Yu JY, DeRuiter SL, Turner DL. RNA interference by expression of short - interfering RNAs and hairpin RNA in mammalian cells [ J ]. Proc Natl Acad Sci USA,2009,9 (10):6047 -6052.

同被引文献11

  • 1Lerman MI,M Naa JD.The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3:Identification and evaluation of the resident candidate tumor suppressor gene[J].Cancer Res,2000,60(21):6116-6133.
  • 2Liu MN,Liu AY,Du YJ,et al.Nitrogen permease regulator-like 2 enhances sensitivity to oxaliplatin in colon cancer cells[J].Mol Med Rep,2015,12(1):1189-1196.
  • 3Tang Y,Jiang L,Tang W.Decreased expression of NPRL2 in renal cancer cells is associated with unfavourable pathological,proliferation and apoptotic features[J].Pathol Oncol Res,2014,20(4):829-837.
  • 4Levine TP,Daniels RD,Wong LH,et al.Discovery of new longin and roadblock domains that form platforms for small GTPases in ragulator and TRAPP-Ⅱ[J].Small GTPases,2013,4(2):62-69.
  • 5Kwak SS,Kang KH,Kim S,et al.Amino acid-dependent NPRL2 interaction with Raptor determines mTOR Complex 1 activation[J].Cell Signal,2016,28(2):32-41.
  • 6Hughes J,Alusi G,Wang Y.Gene therapy and nasopharyngeal carcinoma[J].Rhinology,2012,50(2):115-121.
  • 7Jayachandran G,Ueda K,Wang B,et al.NPRL2 sensitizes human Non-small cell lung cancer(NSCLC) cells to cisplatin treatment by regulating key components in the DNA repair pathway[J].PLoS One,2010,5(8):e11994.
  • 8Yogurtcu B,Hatemi I,Aydin I,et al.NPRL2 gene expression in the progression of colon tumors[J].Genet Mol Res,2012,11(4):4810-4816.
  • 9Otani S,Takeda S,Yamada S,et al.The tumor suppressor NPRL2 in hepatocellular carcinoma plays an important role in progression and can be served as an independent prognostic factor[J].J Surg Oncol,2009,100(5):358-363.
  • 10胡在敏,王川,季文,刘波,蔡璨,姜政.重组质粒pEGFP-N1-NPRL2对人胃癌细胞生物学特性的影响[J].细胞与分子免疫学杂志,2012,28(10):1020-1024. 被引量:5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部